Print
Email
Print Edition Stories
MHT managing editor Rodney Brown on NECN: 22 tech companies give back to community
The Cambridge-based Institute for Pediatric Innovation Inc. has won a half million dollar grant to research children’s medicines globally.
Today, the nonprofit announced that the World Health Organization had awarded it $550,000 to work on this project with Unicef. The goal is to increase the number of medicines designed and formulated specifically for children. To that end, IPI will perform the investigation of preferred dosage forms with children, parents and healthcare providers in Tanzania and two other African countries. This will assist the development of needed children’s medicines, with appropriate dosing guides, for diseases like tuberculosis that require ongoing treatment.
According to IPI, children need to receive medications in dosage forms easily consumed, based on their size and weight. Additionally, the medicines used in the developing world have to be stable in environments with high heat and humidity, be easily transported and come at a low price tag. Frequently, re-formulating an existing medication with these variables in mind can make a “tremendous difference in its efficacy for children,” IPI officials said in a release.
The purpose of IPI is to improve pediatric care by helping the development of medical devices and drugs designed specifically for babies and children. It currently works with a consortium of pediatric hospitals to identify the most needed products. IPI has received support from its consortium members, the Ewing Marion Kauffman Foundation, Children’s Medical Ventures Inc., AGA Medical, and Oxford Bioscience Partners.
RSS Feeds
Comments
Please Login/Register to post comments.
No comments have been added or approved.